COVID-19 AND PARKINSON’S DISEASE
An exciting new study looking at the effect of social isolation due to COVID-19 UK lockdown on the quality of life of Parkinson’s disease patients.
To take part, please visit https://www.smartsurvey.co.uk/s/270RB3/.
Available both for people with Parkinson’s or without.
Centre Of Excellence
King’s Health Partners is one of only two centres in the UK to receive the status of National Parkinson Foundation Centre of Excellence for the treatment and research of Parkinson’s disease.
Led by Professor K Ray Chaudhuri, Director of the National Parkinson Foundation Centre of Excellence at King’s College Hospital and King’s College London, the team spans across neurosciences, nursing and therapies, and provides a full spectrum of services.Read more
Led by Prof K Ray Chaudhuri, EUROPAR is a multidisciplinary group that was formed to perform “real life” non-motor based clinical studies across a wide range of people with Parkinson’s throughout Europe.
The main aim of EUROPAR is to pursue studies as they happen in real life and described as a “holistic” natural history study in Parkinson’s. The study will additionally include people with Parkinson’s who are often excluded from clinical trials e.g. due to their age.Read more
What is Parkinson’s
Parkinson’s disease, first described by James Parkinson in 1817 in An Essay on the Shaking Palsy, is one of the most important disabling illnesses particularly prevalent in later life. It is estimated to affect 1% of 70-year-olds, but is also seen in younger people, with 10% of cases occurring before the age of 50.Read more